Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Biothera initiates dosing in phase III trial of Imprime PGG with Erbitux

May 19, 2011

University of Michigan presents new Smac mimetics with IAP-inhibiting activity

May 19, 2011

Novel protein kinase inhibitors disclosed

May 19, 2011

ERYtech and Teva sign long-term agreement on Graspa

May 18, 2011

Phase II study begins for BKM-120 in recurrent glioblastoma

May 18, 2011

New anticancer antofine and cryptopleurine derivatives disclosed

May 18, 2011

AlloStem Therapeutics designs novel MEK inhibitors

May 18, 2011

Crizotinib NDA filed in Japan for ALK-positive NSCLC and accepted for priority review in U.S.

May 17, 2011

Swissmedic approves Eisai's Halaven for breast cancer

May 17, 2011

Korean scientists claim new protein kinase inhibitors

May 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...